Literature DB >> 4084730

Transurethral incision of prostate (TUIP): 646 cases in 15 years--a chronological appraisal.

A Orandi.   

Abstract

Transurethral incision of the prostate was performed on 646 patients in 15 years. This operation is offered as a surgical cure for bladder outlet obstruction in men of all ages and different sized prostates. In large glands TUIP may not be desirable. Deep incisions cause surgical and sexual complications and may fuse by adhesions. In matched cases this method provided better results and fewer complications than the standard transurethral resection.

Entities:  

Mesh:

Year:  1985        PMID: 4084730     DOI: 10.1111/j.1464-410x.1985.tb07036.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Holmium laser transurethral incision of the prostate: Can prostate size predict the long-term outcome?

Authors:  Mohamed A Elkoushy; Ahmed M Elshal; Mostafa M Elhilali
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 2.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

Review 3.  Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.

Authors:  Matthew Ryan Macey; Mathew C Raynor
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

4.  The T-plasty: a modified YV-plasty for highly recurrent bladder neck contracture after transurethral surgery for benign hyperplasia of the prostate: clinical outcome and patient satisfaction.

Authors:  C P Reiss; C M Rosenbaum; A Becker; P Schriefer; T A Ludwig; O Engel; S Riechardt; M Fisch; R Dahlem
Journal:  World J Urol       Date:  2016-02-12       Impact factor: 4.226

Review 5.  Sexual function in patients with benign prostatic hyperplasia.

Authors:  P K Hegarty; N J Hegarty; J M Fitzpatrick
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.